Unknown

Dataset Information

0

The structure of Abeta42 C-terminal fragments probed by a combined experimental and theoretical study.


ABSTRACT: The C-terminus of amyloid beta-protein (Abeta) 42 plays an important role in this protein's oligomerization and may therefore be a good therapeutic target for the treatment of Alzheimer's disease. Certain C-terminal fragments (CTFs) of Abeta42 have been shown to disrupt oligomerization and to strongly inhibit Abeta42-induced neurotoxicity. Here we study the structures of selected CTFs [Abeta(x-42); x=29-31, 39] using replica exchange molecular dynamics simulations and ion mobility mass spectrometry. Our simulations in explicit solvent reveal that the CTFs adopt a metastable beta-structure: beta-hairpin for Abeta(x-42) (x=29-31) and extended beta-strand for Abeta(39-42). The beta-hairpin of Abeta(30-42) is converted into a turn-coil conformation when the last two hydrophobic residues are removed, suggesting that I41 and A42 are critical in stabilizing the beta-hairpin in Abeta42-derived CTFs. The importance of solvent in determining the structure of the CTFs is further highlighted in ion mobility mass spectrometry experiments and solvent-free replica exchange molecular dynamics simulations. A comparison between structures with solvent and structures without solvent reveals that hydrophobic interactions are critical for the formation of beta-hairpin. The possible role played by the CTFs in disrupting oligomerization is discussed.

SUBMITTER: Wu C 

PROVIDER: S-EPMC2712569 | biostudies-literature | 2009 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

The structure of Abeta42 C-terminal fragments probed by a combined experimental and theoretical study.

Wu Chun C   Murray Megan M MM   Bernstein Summer L SL   Condron Margaret M MM   Bitan Gal G   Shea Joan-Emma JE   Bowers Michael T MT  

Journal of molecular biology 20090123 2


The C-terminus of amyloid beta-protein (Abeta) 42 plays an important role in this protein's oligomerization and may therefore be a good therapeutic target for the treatment of Alzheimer's disease. Certain C-terminal fragments (CTFs) of Abeta42 have been shown to disrupt oligomerization and to strongly inhibit Abeta42-induced neurotoxicity. Here we study the structures of selected CTFs [Abeta(x-42); x=29-31, 39] using replica exchange molecular dynamics simulations and ion mobility mass spectrome  ...[more]

Similar Datasets

| S-EPMC2912417 | biostudies-other
| S-EPMC3899642 | biostudies-other
| S-EPMC5718998 | biostudies-literature
| S-EPMC8069957 | biostudies-literature
| S-EPMC2544597 | biostudies-literature
| S-EPMC6407915 | biostudies-literature
| S-EPMC7540320 | biostudies-literature
| S-EPMC3109503 | biostudies-literature
| S-EPMC7458468 | biostudies-literature
| S-EPMC6656752 | biostudies-literature